Display options
Share it on

Dermatol Surg. 2021 Aug 01;47(8):1165-1166. doi: 10.1097/DSS.0000000000002989.

RZL-012, a New Fat Dissolving Molecule, Tested in Dercum's Disease Patients.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Racheli Gueta, Eran Blaugrund, Alon Bloomenfeld, Karen L Herbst

Affiliations

  1. Raziel Therapeutics Ltd, Rehovot, Israel.
  2. Tucson, Arizona.

PMID: 33867475 DOI: 10.1097/DSS.0000000000002989

[No abstract available.]

References

  1. D'Andrea Molina J, Alborghetti Nai G, Pedro Cordeiro de Andrade TC, Milanez Morgado de Abreu MA. Dercum's disease: a rare and underdiagnosed disease. Ann Bras Dermatol 2019;94:251–3. - PubMed
  2. Herbst KL, Asare-Bediako S. Adiposis Dolorosa is more than painful fat. Endocrinologist 2007;17:326–34. - PubMed
  3. Caffery M, Beebe A. Pain: Clinical Manual for Nursing Practice. Baltimore, MD: V.V. Mosby Company; 1993. - PubMed
  4. Wipf A, Lofgreen S, Miller DD, Farah RS. Novel use of deoxycholic acid for adiposis dolorosa (Dercum disease). Dermatol Surg 2019;45:1718–20. - PubMed

Publication Types